Córdoba Biotech supports 28 innovative projects with training, mentoring, talent acquisition, and access to shared labs for prototype testing and market validation. The program fosters entrepreneurship...
Yazen, supported by investors like Evli Growth Partners and Helsana HealthInvest, plans to triple growth within three years. With new funding, Yazen will expand from Sweden...
Inventiva’s stock surged over 80% on news of phase III trial financing for lanifibranor, targeting NASH liver disease. The €94.1 million initial funding will support trials...
Eli Lilly posted a $970.3 million profit in Q3, boosted by 20.4% growth in sales despite a $1 billion loss in market value. Oversupply issues arose...
Alan's new investment round secures its growth, international expansion, and technology advancements toward profitability by 2026. CEO Jean-Charles Samuelian highlights a partnership with Belfius that supports...
Vytrus Biotech will present its Q3 2024 financials live on November 7, revealing record revenue of €4.6 million in the last year. Q3 sales rose by...
Agomab raised $90 million in Series D funding, led by Asabys, Sanofi, and Invus. Funds will advance clinical trials for its lead fibrosis treatments, including Agmb-129...
Fertinagro Biotech, a leader in sustainable fertilizers, has joined the Huelva Association of Chemical, Basic, and Energy Industries (AIQBE), bringing the Association's total membership to 21...
The AI Act, effective August 1st, classifies AI applications by risk. Minimal risk includes video games, while chatbots require transparency. High-risk categories, such as AI diagnostic...
KFSHRC has improved diagnoses, patient care, and treatment outcomes through AI-driven predictive models, identifying high-risk patients early. AI advancements in radiology increased diagnostic accuracy by 25%,...